<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Frequent Optical Imaging during Breast Cancer Neoadjuvant Chemotherapy Reveals Dynamic Tumor Physiology in an Individual Patient" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/frequent-optical-imaging-during-breast-cancer-neoadjuvant-chemotherapy-reveals-dynamic-tumor-physiol/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/frequent-optical-imaging-during-breast-cancer-neoadjuvant-chemotherapy-reveals-dynamic-tumor-physiol/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2010-07-31T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Frequent Optical Imaging during Breast Cancer Neoadjuvant Chemotherapy Reveals Dynamic Tumor Physiology in an Individual Patient" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-07T07:15:32+00:00","datePublished":"2010-07-31T17:00:00+00:00","description":"Rationale and Objectives","headline":"Frequent Optical Imaging during Breast Cancer Neoadjuvant Chemotherapy Reveals Dynamic Tumor Physiology in an Individual Patient","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/frequent-optical-imaging-during-breast-cancer-neoadjuvant-chemotherapy-reveals-dynamic-tumor-physiol/"},"url":"https://clinicaltree.github.io/posts/frequent-optical-imaging-during-breast-cancer-neoadjuvant-chemotherapy-reveals-dynamic-tumor-physiol/"}</script><title>Frequent Optical Imaging during Breast Cancer Neoadjuvant Chemotherapy Reveals Dynamic Tumor Physiology in an Individual Patient | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Frequent Optical Imaging during Breast Cancer Neoadjuvant Chemotherapy Reveals Dynamic Tumor Physiology in an Individual Patient</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Frequent Optical Imaging during Breast Cancer Neoadjuvant Chemotherapy Reveals Dynamic Tumor Physiology in an Individual Patient</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1280595600" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Jul 31, 2010 </em> </span> <span> Updated <em class="" data-ts="1680851732" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 7, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Albert E. Cerussi PhD</a> </em>, <em> <a href="">Vaya W. Tanamai BS</a> </em>, <em> <a href="">Rita S. Mehta MD</a> </em>, <em> <a href="">David Hsiang MD</a> </em>, <em> <a href="">John Butler MD</a> </em>, <em> <a href="">Bruce J. Tromberg PhD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="2236 words"> <em>12 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Imaging tumor response to neoadjuvant chemotherapy in vivo offers unique opportunities for patient care and clinical decision-making. Detailed imaging studies may allow oncologists to optimize therapeutic drug type and dose based on individual patient response. Most radiologic methods are used sparingly because of cost; thus, important functional information about tumor response dynamics may be missed. In addition, current clinical standards are based on determining tumor size changes; thus, standard anatomic imaging may be insensitive to early or frequent biochemical responses. Because optical methods provide functional imaging end points, our objective is to develop a low-barrier-to-access bedside approach that can be used for frequent, functional assessment of dynamic tumor physiology in individual patients.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>Diffuse Optical Spectroscopic Imaging (DOSI) is a noninvasive, bedside functional imaging technique that quantifies the concentration and molecular state of tissue hemoglobin, water, and lipid. Pilot clinical studies have shown that DOSI may be a useful tool for quantifying neoadjuvant chemotherapy response, typically by comparing the degree of change in tumor water and deoxy-hemoglobin concentration before and after therapy. Patient responses at 1 week and mid-therapy have been used to predict clinical outcome. In this report, we assess the potential value of frequent DOSI monitoring by performing measurements on 19 different days in a 51-year-old subject with infiltrating ductal carcinoma (initial tumor size 60 × 27 mm) who received neoadjuvant chemotherapy (anthracyclines and bevacizumab) over an 18-week period.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>A composite index, the Tissue Optical Index (TOI), showed a significant (∼50%) decrease over the nearly 18 weeks of chemotherapy. Tumor response was sensitive to the type of chemotherapy agent, and functional indices fluctuated in a manner consistent with dynamic tumor physiology. Final pathology revealed 4 mm of residual disease, which was detectible by DOSI at the conclusion of chemotherapy before surgery.</p><h2 id="conclusion"><span class="mr-2">Conclusion</span><a href="#conclusion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>This case study suggests that DOSI may be a bedside-capable tool for frequent longitudinal monitoring of therapeutic functional response to neoadjuvant chemotherapy.</p><p>Presurgical neoadjuvant chemotherapy (NAC) has an increasingly important role in breast cancer patient care and drug development . Also referred to as “preoperative systemic therapy,” NAC has become standard of care for locally advanced and inflammatory breast cancer . In this setting, chemotherapy is administered before surgery to improve breast tissue conservation by reducing tumor size . Additional important benefits compared to adjuvant chemotherapy include the ability to directly assess an individual’s sensitivity to specific drugs, and initiating treatment of possible nodes and metastases before surgery.</p><p>Imaging individual tumor response can provide sufficient information for oncologists to alter therapeutics with a goal of improving overall survival, decreasing cancer recurrence, and minimizing exposure to ineffective drugs. Several groups are developing advanced imaging techniques for monitoring the effects of neoadjuvant chemotherapy, using for example magnetic resonance imaging (MRI) and spectroscopy (MRS), and positron emission tomography (PET) . These studies provide compelling evidence that functional imaging can be used to monitor and perhaps even predict therapeutic outcome . However, it is unclear what are the most sensitive and informative imaging end points and how often they should be assessed.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="instrumentation"><span class="mr-2">Instrumentation</span><a href="#instrumentation" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FrequentOpticalImagingduringBreastCancerNeoadjuvantChemotherapyRevealsDynamicTumorPhysiologyinanIndividualPatient/0_1s20S1076633210002540.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FrequentOpticalImagingduringBreastCancerNeoadjuvantChemotherapyRevealsDynamicTumorPhysiologyinanIndividualPatient/0_1s20S1076633210002540.jpg" alt="Figure 1, Current Diffuse Optical Spectroscopic Imaging (DOSI) instrument. The DOSI instrument measures tissue complete absorption and scattering spectra from 650 to 1000 nm through the use of a handheld probe (seen on top of system). Spectroscopic images are generated by translating the handheld probe along a rectilinear grid on the surface of the breast." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="measured-information-content"><span class="mr-2">Measured Information Content</span><a href="#measured-information-content" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="dosi-measurement-technique"><span class="mr-2">DOSI Measurement Technique</span><a href="#dosi-measurement-technique" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FrequentOpticalImagingduringBreastCancerNeoadjuvantChemotherapyRevealsDynamicTumorPhysiologyinanIndividualPatient/1_1s20S1076633210002540.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FrequentOpticalImagingduringBreastCancerNeoadjuvantChemotherapyRevealsDynamicTumorPhysiologyinanIndividualPatient/1_1s20S1076633210002540.jpg" alt="Figure 2, Measured areas. Dots represent Diffuse Optical Spectroscopic Imaging–measured locations on each breast for the study. At each spatial location, broadband near-infrared absorption and scattering spectra were obtained. The tumor location and orientation is identified by the oval in the figure." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="image-analysis"><span class="mr-2">Image Analysis</span><a href="#image-analysis" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="patient-selection"><span class="mr-2">Patient Selection</span><a href="#patient-selection" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="measurement-and-treatment-schedules"><span class="mr-2">Measurement and Treatment Schedules</span><a href="#measurement-and-treatment-schedules" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="baseline-tumor-nir-absorption-spectra"><span class="mr-2">Baseline Tumor NIR Absorption Spectra</span><a href="#baseline-tumor-nir-absorption-spectra" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FrequentOpticalImagingduringBreastCancerNeoadjuvantChemotherapyRevealsDynamicTumorPhysiologyinanIndividualPatient/2_1s20S1076633210002540.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FrequentOpticalImagingduringBreastCancerNeoadjuvantChemotherapyRevealsDynamicTumorPhysiologyinanIndividualPatient/2_1s20S1076633210002540.jpg" alt="Figure 3, Diffuse Optical Spectroscopic Imaging–measured near infrared absorption spectra. Sample near-infrared absorption spectra from normal and malignant breast tissues before neoadjuvant chemotherapy." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Tumor Functional Properties Measured by DOSI before Chemotherapy</p><p>ctO 2 Hb (μM) ctHHb (μM) ctH 2 O (%) Lipid (%) TOI Tumor 15.0 ± 1.0 9.0 ± 1.2 40.7 ± 5.9 51.4 ± 4.2 7.7 ± 2.8 Normal 13.0 ± 2.2 6.0 ± 1.1 23.0 ± 6.3 71.5 ± 9.5 2.2 ± 1.1</p><p>DOSI, Diffuse Optical Spectroscopic Imaging; ctO 2 Hb, tissue concentration of oxy-hemoglobin; ctHHb, tissue concentration of deoxy-hemoglobin; ctH 2 O, tissue concentration of water; TOI, tissue optical index.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="initial-ac-chemotherapy-stage"><span class="mr-2">Initial A/C Chemotherapy Stage</span><a href="#initial-ac-chemotherapy-stage" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FrequentOpticalImagingduringBreastCancerNeoadjuvantChemotherapyRevealsDynamicTumorPhysiologyinanIndividualPatient/3_1s20S1076633210002540.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FrequentOpticalImagingduringBreastCancerNeoadjuvantChemotherapyRevealsDynamicTumorPhysiologyinanIndividualPatient/3_1s20S1076633210002540.jpg" alt="Figure 4, Serial Diffuse Optical Spectroscopic Imaging images: before initial Adriamycin/Cytoxan. Serial images of tissue concentration of deoxy-hemoglobin (ctHHb) taken before all treatment (-8 days), as well as on days 3, 4, 5, and 7 after the initial Adriamycin/Cytoxan chemotherapy treatment. Each image is scaled independently, with the scale bar immediately to the right of the image. The maximum ctHHb value of the tumor dropped significantly after the treatment (days 3 and 4), but quickly returned to pretreatment levels shortly thereafter (days 5 and 7). Note that the entire tumor volume was not imaged in this example." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="bevacizumab-therapy-stage"><span class="mr-2">Bevacizumab Therapy Stage</span><a href="#bevacizumab-therapy-stage" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FrequentOpticalImagingduringBreastCancerNeoadjuvantChemotherapyRevealsDynamicTumorPhysiologyinanIndividualPatient/4_1s20S1076633210002540.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FrequentOpticalImagingduringBreastCancerNeoadjuvantChemotherapyRevealsDynamicTumorPhysiologyinanIndividualPatient/4_1s20S1076633210002540.jpg" alt="Figure 5, Serial Diffuse Optical Spectroscopic Imaging images after Bevacizumab. Day -7 refers to a week before the initiation of a treatment stage featuring Bevacizumab. The number in parentheses is the day count with respect to the start of all therapy. This patient received Bevacizumab on days 27 and 41. We observed an initial decrease in tissue concentration of deoxy-hemoglobin (ctHHb), yet the peak values of ctHHb returned to the day -7 values after approximately 2 weeks." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="entire-therapy-sequence"><span class="mr-2">Entire Therapy Sequence</span><a href="#entire-therapy-sequence" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FrequentOpticalImagingduringBreastCancerNeoadjuvantChemotherapyRevealsDynamicTumorPhysiologyinanIndividualPatient/5_1s20S1076633210002540.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/FrequentOpticalImagingduringBreastCancerNeoadjuvantChemotherapyRevealsDynamicTumorPhysiologyinanIndividualPatient/5_1s20S1076633210002540.jpg" alt="Figure 6, Long-term tumor response. Tissue optical index (TOI) ratio (tumor/normal) is plotted over the entire course of treatment." class="lazyload" data-proofer-ignore></a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="conclusion-1"><span class="mr-2">Conclusion</span><a href="#conclusion-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="acknowledgments"><span class="mr-2">Acknowledgments</span><a href="#acknowledgments" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Wolff A.C., Berry D., Carey L.A., et. al.: Research issues affecting preoperative systemic therapy for operable breast cancer. J Clin Oncol 2008; 26: pp. 806-813.</p><li><p>2. Gralow J.R., Zujewski J.A., Winer E.: Preoperative therapy in invasive breast cancer: reviewing the state of the science and exploring new research directions. J Clin Oncol 2008; 26: pp. 696-697.</p><li><p>3. Jones R.L., Smith I.E.: Neoadjuvant treatment for early-stage breast cancer: opportunities to assess tumour response. Lancet Oncol 2006; 7: pp. 869-874.</p><li><p>4. Fisher B., Brown A., Mamounas E., et. al.: Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 1997; 15: pp. 2483-2493.</p><li><p>5. Bahri S., Chen J.H., Mehta R.S., et. al.: Residual breast cancer diagnosed by MRI in patients receiving neoadjuvant chemotherapy with and without bevacizumab. Ann Surg Oncol 2009; 16: pp. 1619-1628.</p><li><p>6. Baek H.M., Chen J.H., Nie K., et. al.: Predicting pathologic response to neoadjuvant chemotherapy in breast cancer by using MR imaging and quantitative 1H MR spectroscopy. Radiology 2009; 251: pp. 653-662.</p><li><p>7. Zakhireh J., Gomez R., Esserman L.: Converting evidence to practice: a guide for the clinical application of MRI for the screening and management of breast cancer. Eur J Cancer 2008; 44: pp. 2742-2752.</p><li><p>8. Ah-See M.L., Makris A., Taylor N.J., et. al.: Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer. Clin Cancer Res 2008; 14: pp. 6580-6589.</p><li><p>9. Meisamy S., Bolan P.J., Baker E.H., et. al.: Neoadjuvant chemotherapy of locally advanced breast cancer: predicting response with in vivo (1)H MR spectroscopy—a pilot study at 4 T. Radiology 2004; 233: pp. 424-431.</p><li><p>10. Martincich L., Montemurro F., De Rosa G., et. al.: Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging. Breast Cancer Res Treat 2004; 83: pp. 67-76.</p><li><p>11. Partridge S.C., Gibbs J.E., Lu Y., et. al.: MRI measurements of breast tumor volume predict response to neoadjuvant chemotherapy and recurrence-free survival. AJR Am J Roentgenol 2005; 184: pp. 1774-1781.</p><li><p>12. Duch J., Fuster D., Munoz M., et. al.: (18)F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancer. Eur J Nucl Med Mol Imaging 2009; 36: pp. 1551-1557.</p><li><p>13. Emmering J., Krak N.C., Van der Hoeven J.J., et. al.: Preoperative [18F] FDG-PET after chemotherapy in locally advanced breast cancer: prognostic value as compared with histopathology. Ann Oncol 2008; 19: pp. 1573-1577.</p><li><p>14. Mankoff D.A., Dunnwald L.K., Gralow J.R., et. al.: Changes in blood flow and metabolism in locally advanced breast cancer treated with neoadjuvant chemotherapy. J Nucl Med 2003; 44: pp. 1806-1814.</p><li><p>15. Schelling M., Avril N., Nahrig J., et. al.: Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Clin Oncol 2000; 18: pp. 1689-1695.</p><li><p>16. Mankoff D.A., O’Sullivan F., Barlow W.E., et. al.: Molecular imaging research in the outcomes era: measuring outcomes for individualized cancer therapy. Acad Radiol 2007; 14: pp. 398-405.</p><li><p>17. Tromberg B.J., Pogue B.W., Paulsen K.D., et. al.: Assessing the future of diffuse optical imaging technologies for breast cancer management. Med Phys 2008; 35: pp. 2443-2451.</p><li><p>18. Cerussi A., Shah N., Hsiang D., et. al.: In vivo absorption, scattering, and physiologic properties of 58 malignant breast tumors determined by broadband diffuse optical spectroscopy. J Biomed Opt 2006; pp. 11. 044005</p><li><p>19. Kukreti S., Cerussi A., Tromberg B., et. al.: Intrinsic tumor biomarkers revealed by novel double-differential spectroscopic analysis of near-infrared spectra. J Biomed Opt 2007; pp. 12. 020509</p><li><p>20. Chung S.H., Cerussi A.E., Klifa C., et. al.: In vivo water state measurements in breast cancer using broadband diffuse optical spectroscopy. Phys Med Biol 2008; 53: pp. 6713-6727.</p><li><p>21. Jakubowski D.B., Cerussi A.E., Bevilacqua F., et. al.: Monitoring neoadjuvant chemotherapy in breast cancer using quantitative diffuse optical spectroscopy: a case study. J Biomed Opt 2004; 9: pp. 230-238.</p><li><p>22. Zhu Q., Kurtzma S.H., Hegde P., et. al.: Utilizing optical tomography with ultrasound localization to image heterogeneous hemoglobin distribution in large breast cancers. Neoplasia 2005; 7: pp. 263-270.</p><li><p>23. Shah N., Gibbs J., Wolverton D., et. al.: Combined diffuse optical spectroscopy and contrast-enhanced magnetic resonance imaging for monitoring breast cancer neoadjuvant chemotherapy: a case study. J Biomed Opt 2005; 10: pp. 51503.</p><li><p>24. Choe R., Corlu A., Lee K., et. al.: Diffuse optical tomography of breast cancer during neoadjuvant chemotherapy: a case study with comparison to MRI. Med Phys 2005; 32: pp. 1128-1139.</p><li><p>25. Pham T.H., Coquoz O., Fishkin J.B., et. al.: Broad bandwidth frequency domain instrument for quantitative tissue optical spectroscopy. Rev Sci Instrum 2000; 71: pp. 2500-2513.</p><li><p>26. Bevilacqua F., Berger A.J., Cerussi A.E., et. al.: Broadband absorption spectroscopy in turbid media by combined frequency-domain and steady-state methods. Appl Opt 2000; 39: pp. 6498-6507.</p><li><p>27. Cerussi A.E., Jakubowski D., Shah N., et. al.: Spectroscopy enhances the information content of optical mammography. J Biomed Opt 2002; 7: pp. 60-71.</p><li><p>28. Mourant J.R., Fuselier T., Boyer J., et. al.: Predictions and measurements of scattering and absorption over broad wavelength ranges in tissue phantoms. Appl Opt 1997; 36: pp. 949-957.</p><li><p>29. Cerussi A., Siavoshi S., Durkin A., et. al.: Effect of contact force on breast tissue optical property measurements using a broadband diffuse optical spectroscopy handheld probe. Appl Opt 2009; 48: pp. 4270-4277.</p><li><p>30. Tromberg B.J., Shah N., Lanning R., et. al.: Non-invasive in vivo characterization of breast tumors using photon migration spectroscopy. Neoplasia 2000; 2: pp. 26-40.</p><li><p>31. Pogue B.W., Poplack S.P., McBride T.O., et. al.: Quantitative hemoglobin tomography with diffuse near-infrared spectroscopy: pilot results in the breast. Radiology 2001; 218: pp. 261-266.</p><li><p>32. Franceschini M.A., Moesta K.T., Fantini S., et. al.: Frequency-domain techniques enhance optical mammography: initial clinical results. Proc Natl Acad Sci U S A 1997; 94: pp. 6468-6473.</p><li><p>33. Chance B., Nioka S., Zhang J., et. al.: Breast cancer detection based on incremental biochemical and physiological properties of breast cancers: a six-year, two-site study. Acad Radiol 2005; 12: pp. 925-933.</p><li><p>34. Taroni P., Danesini G., Torricelli A., et. al.: Clinical trial of time-resolved scanning optical mammography at 4 wavelengths between 683 and 975 nm. J Biomed Opt 2004; 9: pp. 464-473.</p><li><p>35. Cerussi A., Hsiang D., Shah N., et. al.: Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy. Proc Natl Acad Sci U S A 2007; 104: pp. 4014-4019.</p><li><p>36. Casanovas O., Hicklin D.J., Bergers G., et. al.: Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors. Cancer Cell 2005; 8: pp. 299-309.</p><li><p>37. Gandjbakhche A.H., Nossal R., Bonner R.F.: Resolution limits for optical transillumination of abnormalities deeply embedded in tissues. Med Phys 1994; 21: pp. 185-191.</p><li><p>38. Pogue B.W., Davis S.C., Song X., et. al.: Image analysis methods for diffuse optical tomography. J Biomed Opt 2006; 11: pp. 33001.</p><li><p>39. Li A., Liu J., Tanamai W., et. al.: Assessing the spatial extent of breast tumor intrinsic optical contrast using ultrasound and diffuse optical spectroscopy. J Biomed Opt 2008; pp. 13. 030504</p><li><p>40. Yeh E., Slanetz P., Kopans D.B., et. al.: Prospective comparison of mammography, sonography, and MRI in patients undergoing neoadjuvant chemotherapy for palpable breast cancer. AJR Am J Roentgenol 2005; 184: pp. 868-877.</p><li><p>41. Warren R.M., Bobrow L.G., Earl H.M., et. al.: Can breast MRI help in the management of women with breast cancer treated by neoadjuvant chemotherapy?. Br J Cancer 2004; 90: pp. 1349-1360.</p><li><p>42. No K.S., Kwong R., Chou P.H., et. al.: Design and testing of a miniature broadband frequency domain photon migration instrument. J Biomed Opt 2008; pp. 13. 050509</p><li><p>43. Boas D.A., O’Leary M.A., Chance B., et. al.: Detection and characterization of optical inhomogeneities with diffuse photon density waves: a signal-to-noise analysis. Appl Opt 1997; 36: pp. 75-92.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-17/'>Volume 17</a>, <a href='/categories/issue-8/'>Issue 8</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Frequent%20Optical%20Imaging%20during%20Breast%20Cancer%20Neoadjuvant%20Chemotherapy%20Reveals%20Dynamic%20Tumor%20Physiology%20in%20an%20Individual%20Patient%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Ffrequent-optical-imaging-during-breast-cancer-neoadjuvant-chemotherapy-reveals-dynamic-tumor-physiol%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Frequent%20Optical%20Imaging%20during%20Breast%20Cancer%20Neoadjuvant%20Chemotherapy%20Reveals%20Dynamic%20Tumor%20Physiology%20in%20an%20Individual%20Patient%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Ffrequent-optical-imaging-during-breast-cancer-neoadjuvant-chemotherapy-reveals-dynamic-tumor-physiol%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Ffrequent-optical-imaging-during-breast-cancer-neoadjuvant-chemotherapy-reveals-dynamic-tumor-physiol%2F&text=Frequent%20Optical%20Imaging%20during%20Breast%20Cancer%20Neoadjuvant%20Chemotherapy%20Reveals%20Dynamic%20Tumor%20Physiology%20in%20an%20Individual%20Patient%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/cade-prompts-and-observer-performance/"><div class="card-body"> <em class="small" data-ts="1280595600" data-df="ll" > Jul 31, 2010 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>CADe Prompts and Observer Performance</h3><div class="text-muted small"><p> In computed tomographic (CT) colonography, also known as virtual colonoscopy, patients are typically scanned in two positions . By comparing the two CT scans, radiologists can maximize the visible ...</p></div></div></a></div><div class="card"> <a href="/posts/ct-colonography-computer-aided-polyp-detection/"><div class="card-body"> <em class="small" data-ts="1280595600" data-df="ll" > Jul 31, 2010 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>CT Colonography Computer-Aided Polyp Detection</h3><div class="text-muted small"><p> Rationale and Objectives To determine whether the display of computer-aided detection (CAD) marks on individual polyps on both the supine and prone scans leads to improved polyp detection by radio...</p></div></div></a></div><div class="card"> <a href="/posts/curriculum-development-for-medical-education-a-six-step-approach-2nd-edition/"><div class="card-body"> <em class="small" data-ts="1280595600" data-df="ll" > Jul 31, 2010 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Curriculum Development For Medical Education A Six-Step Approach, 2nd Edition</h3><div class="text-muted small"><p> The second edition of The Johns Hopkins University Press’s outstanding book Curriculum Development for Medical Education: A Six-Step Approach is a tour-de-force and a voyage of discovery, and I ver...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/frequency-and-diagnostic-utility-of-intralabyrinthine-flair-hyperintensity-in-the-evaluation-of-inte/" class="btn btn-outline-primary" prompt="Older"><p>Frequency and Diagnostic Utility of Intralabyrinthine FLAIR Hyperintensity in the Evaluation of Internal Auditory Canal and Inner Ear Pathology</p></a> <a href="/posts/home-sweet-home/" class="btn btn-outline-primary" prompt="Newer"><p>Home Sweet Home</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
